Merck KGaA

Merck to Acquire US Biopharma Company SpringWorks Therapeutics

Merck and biopharmaceutical company SpringWorks Therapeutics, have entered into a definitive agreement for Merck to acquire SpringWorks.

Merck Partners with Afrigen Biologics on mRNA Vaccines

German chemicals, pharmaceuticals and life sciences group Merck entered a non-binding Memorandum of Understanding (MoU) with Afrigen Biologics to support the development of an mRNA vaccine technology platform. The collaboration is aimed at advancing mRNA platform manufacturing capabilities, scaling up production, optimizing processes, and providing troubleshooting expertise, the companies said.

Decarbonizing for a Sustainable Future

Reducing greenhouse gas (GHG) emissions in the supply chain lies outside of a company’s direct control, so collaboration with suppliers and partners in the supply chain is key.

Transition Metals in Catalysis: From Precious to Practical

Download this complimentary Article Collection today!

Merck Opens New €20 Million Distribution Center in Brazil

Merck will open a new € 20 million distribution center in São Paulo, Brazil to better serve its Life Science customers in the region. The new space, which will be operational in late February, has an area of 13,000 square meters, which is twice as large as the former São Paulo location.

Merck Establishes Digital Hub in Singapore

German chemicals, pharmaceuticals and life sciences group Merck has opened a digital hub in Singapore, the first outside of the US and Europe for its digital business.

Germany’s Merck Signs MoU on Korean Biotech Hub

Germany’s Merck said this week it has signed a non-binding Memorandum of Understanding (MoU) with South Korea’s Ministry of Trade, Industry and Energy (MOTIE), and Daejeon City to establish a new Asia-Pacific BioProcessing Center.

Merck Germany Doubles HPAPI Potential

The Life Science business segment of German pharmaceuticals, chemicals and life sciences group Merck has widened its US plant for high-potent active pharmaceutical ingredients (HPAPIs) at Verona, near Madison, Wisconsin to 6,500 m2.

Proactive Supplier Risk Mitigation for Manufacturing and Testing Organizations

There is a new urgency in the market for manufacturers and testing organizations to be prepared for rapid, unexpected changes in material resource access, exacerbated by turbulent regional and global events. This focus is in addition to reinforcing routine risk mitigation activities around the raw material supply chain, adding to the relevance and impact of the topic.

Merck Innovation Cup 2021

The Innovation Cup is an initiative for post-graduate students and young professionals in natural sciences, computer sciences, and business administration to attend a training program near Frankfurt, Germany.

Merck KGaA Acquires Flo Design Sonics

Germany’s Merck and FlexEnable Find Plastic LCD

Merck KGaA Gets Credit Ratings Upgrade from Moody's, S&P

Merck Millipore Sees China As Strongest Growth Market

Merck Resumes Xirallic Production in Japan

Karl-Ludwig Kley: Merck KGaA May Sell Non-Prescription Drugs Business

EU Drug Watchdog Recommend Against Merck KGaA's Cladribine

EU Drug Watchdog Recommend Against Merck KGaA's Cladribine

Beijing Skywing Technology Acquired by Merck KGaA

Intensive Cooperation

Uta Kemmerich-Keil: Merck KGaA to Refrain From Big Deals For Now

Merck Warns of Slower Chemical Sector Growth

Merck Chemicals: New Material Research Center

Securing Each Step

Driven By Innovation

Merck KGaA Profit After Tax Jumps 70% to €187 Million in Q2 2010

'A Merger For Growth'

Is Merck KGaA's $6 Billion Bid for Millipore Too Costly?

Update: Merck KGaA Buys Millipore to Stabilize Business

Germany's Merck to Buy Millipore in $6 Billion Deal

Merck Sees Chemical, Pharma Acquisitions

Merck: Pharmaceutical Raw Materials Production Plant in the Works